Evidence map›Paper›PMID 42168313›Full record

ArticleScientific reports2026

Design and classify innovative antimicrobial and dual- and multi-functional peptides using generative artificial intelligence.

Alexa Sowers, Jinge Wang, Gangqing Hu, Malcolm Xing, Bingyun Li

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexa SowersDepartment of Orthopaedics, School of Medicine, West Virginia University, Morgantown, WV, 26506, USA.
Jinge WangDepartment of Microbiology, Immunology & Cell Biology, West Virginia University, Morgantown, WV, 26506, USA.
Gangqing HuDepartment of Microbiology, Immunology & Cell Biology, West Virginia University, Morgantown, WV, 26506, USA. michael.hu@hsc.wvu.edu.
Malcolm XingDepartment of Mechanical Engineering, University of Manitoba, Winnipeg, MB, R3T 2N2, Canada.
Bingyun LiDepartment of Orthopaedics, School of Medicine, West Virginia University, Morgantown, WV, 26506, USA. bili@hsc.wvu.edu.

Funding

WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI GARY O RANKIN · 2012 to 2026
$61.1M
NIGMS NIH HHS P20 GM103434NIH HHS P20 GM103434NSF 2125872
6 · The paper itself

Abstract

Antimicrobial resistance is a growing global crisis, where antimicrobial peptides (AMPs) have emerged as promising alternatives to conventional antibiotics due to their unique mechanisms of action. However, traditional peptide design approaches, especially when designing multi-functional peptides, are often costly and time-consuming. This study explores the potential of ChatGPT as a prompt-based tool used without additional fine-tuning, for the classification and design of peptides with varying degrees of functional capabilities. We optimized the AMP design prompts by incorporating relevant information and refining them to design multi-functional peptides. For peptide classification, representative examples of positive and negative sequences were sourced from databases specific to each functionality, and a small exploratory set (10 positive sequences and 10 negative sequences) from the respective databases were randomly selected. In this preliminary evaluation, ChatGPT designed single- and dual-functional peptides with a promising apparent performance (accuracy > 0.9) and a decreased performance for triple- and quadruple-functional peptides (accuracy of 0.8) based on in silico testing. Additionally, ChatGPT showed promising preliminary results in classifying peptides with antimicrobial, non-hemolytic, cell-penetrating, and anticancer properties. Incorporating in-context example sequences significantly improved its classification performance. This work provides a proof-of-concept study of using a generative artificial intelligence tool for classification and multi-functional peptide design. While experimental validation is required, these findings suggest that accessible, non-coding Large Language Model approaches may support early-stage in silico peptide discovery that may be used in combination with existing computational tools.

Indexed as

Anti-Infective AgentsAntimicrobial PeptidesDrug DesignArtificial IntelligenceGenerative Artificial IntelligenceAnti-Infective AgentsAntimicrobial PeptidesAI-driven drug designBioactive peptide designGenerative artificial intelligenceMulti-functional peptideTherapeutic peptide

Identifiers

PMID42168313
PMCPMC13408960

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.